Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling

Circulation

Volumn 96, Issue 11, 1997, Pages 3963-3973

  Fraccarollo, Daniela ^c   Hu, Kai ^c   Galuppo, Paolo ^c   Gaudron, Peter ^c   Ertl, Georg ^b   Mann, Douglas ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE

Author keywords

Endothelin; Myocardial infarction; Receptors

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; BOSENTAN; CATECHOLAMINE; DOPAMINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; NORADRENALIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0030691955     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.11.3963     Document Type: Article

References (48)

1. Francis GS. Neurohumoral mechanism involved in congestive heart failure. Am J Cardiol. 1985;55:15-21.
2. Parmley WW. Pathophysiology of congestive heart failure. Am J Cardiol. 1985;55:9-14.
3. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt M. Regional cardiac dilatation after acute myocardial infarction. N Engl J Med. 1979;300:57-62.
4. White HD, Morris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
6. Gaudron P, Eilles C, Ertl G, Kochsiek K. Early remodelling of the left ventricle in patients with myocardial infarction. Eur Heart J. 1990;11:139-146.
7. Gaudron P, Eilles C, Ertl G, Kochsiek K. Compensatory and noncompensatory left ventricular dilatation after myocardial infarction: time course, hemodynamic consequences at rest and exercise. Am Heart J. 1992;123:377-385.
8. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755-763.
9. Raya TE, Gay RG, Aguirre M, Goldman S. Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine. Circ Res. 1989;64:330-337.
10. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy On the infarcted left ventricle of the rat. Circ Res. 1985;57:84-95.
11. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-677.
12. Yamagishi H, Kim S, Nishikimi T, Takcuchi K, Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodeling in myocardial-infarcted rats, J Mol Cell Cardiol. 1993;25:1369-1380.
13. Makino N, Hata T, Sugano M, Dixon IMC, Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. J Mol Cell Cardiol. 1996;28:507-517.
14. Bruckschlegel G, Holmer SR, Jandeleit K, Grimm D, Muders F, Kromer EP, Riegger GAJ, Sehunkert H. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension. 1995;25:250-259.
15. Baker KM, Chernin MI, Wixson SK, Aceto JF. The renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.
16. Tomada H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J. 1993;125:667-672.
17. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation. 1994;89:1573-1579.
18. Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin in acute ischemic syndromes. Br Heart J. 1992;67:383-386.
19. Wei CM, Lerman A, Rodeheffer RJ, McGregor CGA, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC. Endothelin in human congestive heart failure. Circulation. 1994;89:1580-1586.
20. Teerlink JR, Loeffler BM, Hess P, Marie JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Circulation. 1994;90:2510-2518.
21. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol. 1988;255:H970-H973.
22. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive chronotropic effects of endothelin: a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch. 1988;413:108-110.
23. Li K, Stewart DJ, Rouleau JL. Myocardial contractile actions of endothelin-1 in rat and papillary muscles. Circ Res. 1990;69:301-312.
24. Takanashi M, Endoh M, Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol. 1991;261:H611-H619.
25. Aral M, Yoguchi A, Iso T, Takahashi T, Imai S, Murata K, Suzuki T. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am J Physiol. 1995;268:H2084-H2091.
26. Sakai S, Miyauchi T, Sahurai T, Kasuya Y, Ihara M, Yamaguchi I, Goto K, Sugishita Y. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart. Circulation. 1996;93:1214-1222.
27. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996;384:353-355.
28. Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987;30:73-110.
29. McKay RG, Pfeffer MA, Pasternak RC, Markis J, Come PC, Nakao S, Alderman JD, pergnson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693-702.
30. Hochmann JS, Bulkley BH. Expansion of acute myocardial infarction: an experimental study. Circulation. 1982;65:1446-1450.
31. Clozel M, Breu V, Gray GA, Kalina B, Loeffler BM, Burri K, Cassal JM, Hirth G, Moeller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active non-pepticle endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228-235.
32. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503-512.
33. Ishikawa T, Li L, Shinmi O, Kimura M, Yanagisawa M, Goto K, Masaki T. Characteristics of binding of endothelin-1 and endothelin-3 to rats hearts: developmental changes in mechanical responses and receptor subtypes. Circ Res. 1991;69:918-926.
34. Lowry OH, Roseborough NJ, Fair AL, Randall RJ, Protein measurement with the Folin reagent. J Biol Chem. 1951;193:265-275.
35. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effects on systolic function. Circ Res. 1981;49:618-626.
36. Sakai S, Miyauchi T, Sahurai T, Yamaguchi I, Kobayashi M, Goto K, Sugishita Y. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. J Am Coll Cardiol. 1996;28:1580-1588.
37. Fishbein MC, Lei LQ, Rubin SA. Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction. Circulation. 1988;78:369-375.
38. Howes LG, Hodsman GP, Maccarone C, Kohzuki M, Johnston CI. Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels in a rat model of left ventricular failure. J Cardiovasc Pharmacol. 1989;13:348-352.
39. Loeffler BM, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett. 1993;333:108-110.
40. ω-nitro-L-arginine methyl ester. Hypertension. 1996;28:188-195.
41. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldbausl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelin cells. J Biol Chem. 1992;267:16066-16068.
42. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 1991;68:856-869.
43. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Tanigychi K, Marymo F. ET-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991;69:209-215.
44. Miyauchi T, Yorikane R, Sakai S, Sakurai M, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993;73:887-897.
45. Ito H, Hiroe M, Hirata Y, Fujisaki H, Adacbi S, Akimoto H, Ohta Y, Marumo F. Endothelin ETa receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation. 1994;89:2198-2203.
46. Yorikane R, Sakai S, Miyauchi T, Sahurai T, Goto K. Possible involvement of endothelin-1 in cardiac hypertrophy. Drug Res. 1994;44:412-415.
47. de Simone G, Devereux RB, Roman MJ, Ganau A, Chien S, Alderman MH, Atlas S, Laragh JH. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol. 1991;68:1704-1708.
48. Cabral AM, Vasquez EC, Moyses MR, Antonio A. Sex hormone modulation of ventricular hypertrophy in sinoaortic denervated rats. Hypertension. 1988;11(suppl I):I-93-I-97.